Brain Metastases in Havana Cancer Patients

Joel Caballero-García1, Rosainerys Jiménez-Martínez2, Adolfo M Giol-Álvarez3

  • 1National Oncology and Radiobiology Institute (INOR), Havana, Cuba.

MEDICC Review
|July 7, 2021
PubMed

Insights

Brain metastases are more common in this Cuban municipality than previously reported, affecting 23% of cancer patients. Early detection of brain metastases is crucial for improving patient outcomes and quality of life.

Area of Science:

  • Neuro-oncology
  • Epidemiology
  • Public Health

Background:

  • Cancer poses a significant global and Cuban public health challenge.
  • Brain metastases affect approximately one-third of cancer patients.
  • Epidemiological data on brain metastases, particularly in Cuba, are limited, with most research based on autopsy or case series.

Purpose of the Study:

  • To characterize brain metastases patients in Habana del Este Municipality, Havana, Cuba.
  • To analyze demographics, primary tumor sites, and metastasis locations.
  • To provide foundational epidemiological data for this specific Cuban population.

Main Methods:

  • Retrospective descriptive study of cancer patients diagnosed in 2014.
  • Utilized computed tomography and/or magnetic resonance imaging reports.
  • Analyzed variables including age, sex, metastasis location, and primary tumor site.

Main Results:

  • Identified 832 cancer patients; 23% (191/832) had brain metastases.
  • Prevalence of brain metastases was 105.2 per 100,000 population.
  • Most affected: females (61.3%), aged 41-60 (48.2%), with multiple metastases (59.7%).
  • Common primary sites: breast (40.8%) and lung (31.9%). Parietal lobe was the most frequent metastasis site (46.8%).

Conclusions:

  • Brain metastases prevalence in this Cuban municipality exceeds international reports.
  • Brain metastases represent a higher proportion of cancer cases compared to other population studies.
  • Emphasizes the need for early brain metastasis detection to improve quality of life and survival.
Abstract